Medicine and Dentistry
Patient with Diabetes
76%
Cardiovascular System
60%
Thrombosis
38%
In Vitro
38%
Goblet Cell
38%
Right Coronary Artery
38%
Coronary Artery Disease
38%
Type D Behavior
38%
Fibroin
38%
Gelatin
38%
Peritoneal Dialysis
38%
Carcinoid
38%
Annulus Fibrosus
38%
Angina pectoris
38%
Peritonitis
38%
Non ST Segment Elevation Myocardial Infarction
38%
Blood Pressure
38%
Mitral Valve Stenosis
38%
Functional Status
38%
Cotransporter
38%
Vertebra
38%
Adolescent Idiopathic Scoliosis
38%
Kyphosis
38%
Spinal Fusion
38%
Myocardial Infarction
31%
Diabetes Mellitus
30%
Abdominal Pain
25%
Angioplasty
25%
Heart Failure
22%
New York Heart Association Class
21%
Coronary Angiography
18%
Chronic Kidney Disease
16%
Nephropathy
16%
Systolic Blood Pressure
15%
Diastolic Blood Pressure
15%
Patient with Hypertension
15%
Appendectomy
12%
Acute Appendicitis
12%
Intermediate Risk Population
12%
Blood Clot Lysis
12%
Subgroup Analysis
12%
Mortality Rate
12%
Low Risk Population
12%
High Risk Population
12%
Cardiogenic Shock
12%
Acute Kidney Injury
12%
Cardiology
12%
Abciximab
12%
Speckle Tracking Echocardiography
10%
Contrast-Induced Nephropathy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Heart Infarction
86%
Acute Heart Infarction
76%
Rivaroxaban
76%
Atrial Fibrillation
76%
Chronic Kidney Failure
54%
Heart Failure
54%
All Cause Mortality
50%
Dipeptidyl Carboxypeptidase Inhibitor
47%
Angiotensin Receptor Antagonist
47%
Non ST Segment Elevation Myocardial Infarction
47%
Coronary Artery Disease
38%
Antiplatelet
38%
Functional Status
38%
End Stage Renal Disease
38%
Cotransporter
38%
Thrombosis
38%
Mitral Valve Stenosis
38%
Warfarin
38%
Chronic Fatigue Syndrome
38%
Bleeding
31%
Diabetes Mellitus
30%
Cardiovascular Disease
23%
Mortality Rate
22%
Kidney Disease
16%
Acute Kidney Failure
12%
Cardiogenic Shock
12%
Abciximab
12%
Thromboembolism
11%
Disease Exacerbation
10%
Symptom
10%
Contrast Induced Nephropathy
10%
ST Segment Elevation Myocardial Infarction
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Beta Adrenergic Receptor Blocking Agent
9%
Brain Ischemia
7%
Disease
7%
Ischemia
6%
Diuretic Agent
5%
Prevalence
5%
Comorbidity
5%
Replacement Therapy
5%
Kidney Injury
5%
Clinical Research
5%
Nursing and Health Professions
Heart Failure
41%
Coronary Artery Disease
38%
Blood Pressure
38%
Cotransporter
38%
Mitral Valve Stenosis
38%
Thrombosis
38%
Patient with Diabetes
38%
Functional Status
38%
Chronic Fatigue Syndrome
38%
Heart Muscle Revascularization
22%
Odds Ratio
22%
New York Heart Association Class
21%
Kidney Disease
16%
Chronic Kidney Failure
16%
Systolic Blood Pressure
15%
Diastolic Blood Pressure
15%
Patient with Hypertension
15%
Hazard Ratio
15%
Heart Infarction
15%
Contrast Induced Nephropathy
10%
Disease Exacerbation
10%
Symptom
10%
Speckle Tracking Echocardiography
10%
Analysis of Covariance
7%
Hospital
7%
Outpatient
7%
Proportional Hazards Model
7%
Logistic Regression Analysis
7%
Disease
7%
Comorbidity
5%
Renal Replacement Therapy
5%
Coronary Angiography
5%
Kidney Injury
5%
Diabetes Mellitus
5%
Prevalence
5%
Computed Tomographic Angiography
5%
Population
5%
Imaging
5%
Heart Left Ventricle Ejection Fraction
5%
Multivariate Analysis
5%
Pressure Gradient
5%
Color Doppler Echocardiography
5%
Two Dimensional Speckle Tracking Echocardiography
5%
Lung Artery Pressure
5%
Diuretic Agent
5%
